BioSpace News Archive

RNA Disease Diagnostics, Inc., a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced the appointment of Richard G. Ganz to its Board of Directors.

Medolife Rx, Inc. (“Medolife”), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today new clinical observations made on its lead drug candidate Escozine®.

Today, Akston Biosciences Corporation , a developer of new classes of biologic therapeutics announced positive results from a 60-subject, open-label, Phase I trial of AKS-452, its protein subunit, room temperature stable, COVID-19 vaccine candidate.

NeurOptics, the worldwide leader in the science of pupillometry, announced the U.S. launch of its NPi®-300, a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients.

The Fetal Institute, Miami, which specializes in the assessment, counseling, and management of patients with high-risk pregnancies, is conducting a clinical trial of fetoscopic repair in open spina bifida, a minimally invasive procedure developed by doctors at the Institute and the USFetus in collaboration with colleagues in Brazil.

Vect-Horus and RadioMedix are pleased to announce the FDA clearance of exploratory Investigational New Drug (eIND) application to evaluate 68 Ga-RMX-VH for the detection and mapping of Low Density Lipoprotein Receptor (LDLR) overexpressed in Glioblastoma Multiforme (GBM).

Sunshine Biopharma Inc. today announced that it has succeeded in inhibiting the activity of Nrf2 using mRNA vaccine technology. Nrf2 is a transcription factor responsible for activation of oxidative stress genes as well as the cancer multidrug resistance genes, MDR1 (p-Glycoprotein), MRP1 and BCRP.

Elevar Therapeutics, Inc. today announced the expansion of its executive and senior leadership teams with the appointments of experienced industry leaders to several key roles, including Maureen Conlan, M.D., F.A.C.P., to Chief Medical Officer (CMO) and member of the executive leadership team, Julie Boisvert to Vice President (VP), Regulatory Affairs, and Dominick DiPaolo to VP, Quality Assurance.

PharmaCyte Biotech, Inc. today announced that all 4 proposals presented to the Company’s stockholders for a vote at the 2021 Annual Meeting of Stockholders have passed.

Hancock Jaffe Laboratories, Inc., a developer of medical devices that restore cardiac and vascular health, announced that Robert Berman, CEO of Hancock Jaffe will present at the Ladenburg Thalmann 2021 Healthcare Conference on Tuesday, July 13, 2021 at 1:00 PM ET.